Exercise Cuts Mortality in Diabetes

Steven Fox

August 06, 2012

August 6, 2012 — In patients with diabetes mellitus, even moderate levels of regular exercise can reduce risk for death by up to 38%, according to a newly published study that combines prospective cohort data with a meta-analysis of 12 previous studies.

The new study was published online August 6 in the Archives of Internal Medicine.

The authors, led by Diewertje Sluik, MSc, from the German Institute of Human Nutrition Potsdam-Rehbrücke, in Nuthetal, Germany, note that physical activity (PA) has long been considered a cornerstone of diabetes management. However, they write, "Several prospective cohort studies have found that higher PA levels were associated with reduced [cardiovascular disease (CVD)] and total mortality rates, but conclusive high-level evidence is lacking."

Therefore, the researchers conducted a prospective cohort study of 5859 patients with diabetes who had been enrolled from 1992 to 2000 in the ongoing European Prospective Investigation Into Cancer and Nutrition (EPIC) study. Participants ranged in age from 35 to 70 years.

"No information was available to distinguish type 1 and 2 diabetes mellitus," the authors write. "To be considered diabetic, a self-reported diagnosis at baseline had to be confirmed by at least 1 additional information source."

The researchers used multivariable Cox proportional hazards regression models to assess how patients' reported leisure-time PA, total PA, and walking were associated with cardiovascular disease and total mortality.

They found that total PA was associated with lower risk for CVD and total mortality. "Compared with physically inactive persons, the lowest mortality risk was observed in moderately active persons: hazard ratios were 0.62 (95% [confidence interval (CI)], 0.49-0.78) for total mortality and 0.51 (95% CI, 0.32-0.81) for CVD mortality," the authors write. Leisure-time PA was also associated with lower total mortality, and walking was linked to reduced risk for mortality from cardiovascular disease.

To further assess the association between exercise and mortality, the researchers also conducted a meta-analysis of 12 previous prospective studies, which had been conducted through 2010. All studies focused on various aspects of how PA affects diabetes.

"In the meta-analysis, the pooled random-effects hazard ratio from 5 studies for high vs low total PA and all-cause mortality was 0.60 (95% CI, 0.49-0.73)," the authors write.

"These associations are in line with those found in the general population, where PA relates to a 33% lower risk of overall mortality and a 35% lower risk of CVD mortality compared with inactivity," the authors note.

The investigators conclude that evidence from their present study, coupled with data from the meta-analysis, supports the widely held belief that PA cuts mortality risk in people with diabetes.

However, they note that patients with diabetes often have trouble adhering to exercise programs. With that in mind, they note, "[F]uture research should elucidate the determinants of physical inactivity and design successful strategies to promote active lifestyles."

In an editorial accompanying the study, Mitchell Katz, MD, from the Los Angeles County Department of Health Services in California, says it is important for physicians to be aware of the physiologic effects and benefits of various types of exercise, so they can appropriately counsel their patients.

He notes that instructions on how to write exercise prescriptions are readily available on a Web site provided by the US Department of Veterans Affairs.

"Some might question whether providing exercise prescriptions is really the job of the practicing physician, a fair question given that we are all trying to do more in our 15-minute visits," Dr. Katz writes. "But having read the meta-analysis by Sluik et al., I cannot help but note that none of the time I spend trying to decide whether to increase the dose or add a new medication for my patients with type 2 diabetes is likely to result in a 38% reduction in all-cause mortality."

This study was supported by a grant from the European Foundation for the Study of Diabetes/sanofi-aventis. The authors of the study and the editorialist have disclosed no relevant financial relationships.

Arch Intern Med. Published online August 6, 2012. Article abstract, Editorial full text


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.